NHS England backs tighter control on drugs spending,which opponents say would set treatment ‘back by a generation’Patient groups occupy reacted with alarm to plans to reassess the value to the NHS of many cancer drugs, which is likely to mean that some will be phased out because they do not offer value for money.
A board assembly of NHS England has endorsed proposals that will impose much tighter control of spending on cancer drugs, and requiring all those that occupy been paid for by the government’s £340m Cancer Drugs Fund to be re-evaluated by the National Institute for Health and Care Excellence (Nice). Continue reading...
Source: theguardian.com